Category: Top Story
-

Actelis Networks Shares Jump After Securing Major German Utility Contract
Actelis Networks Inc. (NASDAQ:ASNS) shares surged 9.5% on Wednesday after the cyber-hardened networking solutions provider announced a new contract with one of Central Germany’s largest regional utility companies. Under the agreement, Actelis will deliver its hybrid fiber-copper networking technology — equipped with military-grade encryption — to support the utility’s water, gas, and electricity distribution networks.…
-

Willdan Shares Gain After Winning $97 Million Energy Efficiency Contract in Alameda County
Willdan Group Inc. (NASDAQ:WLDN) shares rose 2.6% on Wednesday after the engineering and energy solutions company announced it had secured a $97 million energy savings performance contract from Alameda County, California. Under the agreement, Willdan will design and implement large-scale energy and infrastructure upgrades across 24 county facilities, including electrification of HVAC systems, solar photovoltaic…
-

Baytex Energy Shares Jump After $3.25 Billion Sale of Eagle Ford Assets
Baytex Energy Corp. (NYSE:BTE) shares soared 13% on Wednesday after the Canadian oil producer announced the sale of its U.S. Eagle Ford assets for US$2.305 billion (about $3.25 billion) in cash — a transformative move that will sharpen its focus on its domestic operations. The company said the transaction, which is expected to close in…
-

Eledon Pharmaceuticals Shares Sink After Announcing $50 Million Public Offering
Eledon Pharmaceuticals Inc. (NASDAQ:ELDN) shares tumbled 17.8% in premarket trading on Wednesday after the biopharmaceutical firm announced the pricing of a $50 million underwritten public offering, sparking investor concerns over dilution. The company said it will issue 15,152,485 shares of common stock at $1.65 per share and pre-funded warrants to purchase up to 15,151,515 additional…
-

VisionSys AI Shares Collapse After Announcing Highly Dilutive Stock Offering
VisionSys AI Inc. (NASDAQ:VSA) shares plummeted 75% in premarket trading on Wednesday after the brain-machine interaction technology company unveiled a deeply dilutive registered direct offering, sparking investor concerns over significant share dilution. The company said it had entered into securities purchase agreements with institutional investors to sell 9,230,750 American Depositary Shares (ADS), along with warrants…
-

Cogent Biosciences Shares Slip After Announcing $500 Million Fundraising Plan
Cogent Biosciences Inc. (NASDAQ:COGT) shares dropped 2.4% in premarket trading Wednesday after the biotechnology firm priced two public offerings worth a combined $500 million to strengthen its balance sheet and fund ongoing development programs. The company announced it had upsized its equity offering to 9,677,420 shares at $31.00 per share, raising about $300 million, an…
-

IperionX Shares Drop After Spruce Point Issues Critical Short Report
IperionX Limited ADR (NASDAQ:IPX) shares fell 5.6% in premarket trading Wednesday after Spruce Point Capital Management published a short report on the titanium producer, warning of a potential long-term downside of 70% to 95% under certain conditions. The New York-based investment firm raised doubts about IperionX’s commercial prospects and valuation in a report titled “A…
-

DBV Technologies Shares Jump After Completing Final Phase of VITESSE Peanut Allergy Trial
DBV Technologies (NASDAQ:DBVT) shares surged 7.2% in premarket trading on Wednesday after the French biopharmaceutical company announced the completion of the final patient visit in its Phase 3 VITESSE trial evaluating the VIASKIN Peanut patch. The study assesses the efficacy and safety of the VIASKIN Peanut patch in children aged 4 to 7 years with…
-

BIO-Key Shares Surge After Strategic Partnership With VaporVM
BIO-Key International, Inc. (NASDAQ:BKYI) shares jumped 9.7% in premarket trading on Wednesday after the company announced a strategic partnership with Dubai-based cloud and cybersecurity firm VaporVM. The collaboration is designed to expand BIO-Key’s presence across the Middle East and Africa, combining its advanced identity authentication technologies with VaporVM’s strong regional network and market expertise. As…
-

Alkermes Shares Plunge After Mixed Market Reaction to Narcolepsy Drug Trial Results
Alkermes (NASDAQ:ALKS) shares fell 15% after the company released topline results from its Vibrance-2 Phase 2 trial of alixorexton in patients with narcolepsy type 2. Despite demonstrating strong efficacy, the data failed to fully convince investors. The Dublin-based biopharma firm reported that alixorexton met both primary endpoints, showing statistically significant improvements in wakefulness and excessive…